Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor for coronary slow flow phenomenon
ACTRN12616000388415Phase 4Terminated
- Sponsor
- University of Adelaide
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ticagrelor in Slow Coronary Flow (SCF) (2 arms), sponsored by University of Adelaide. Primary endpoint: Angina frequency. Started Jul 2016; status: terminated.
02
Drugs
ticagrelor
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on ACTRN12616000388415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000388415.